A recent case of severe, but reversible, hypoplastic anemia was associated temporally with lindane exposure. A series of 46 cases of hematotoxicity associated with lindane is reviewed, and the weaknesses in the indictment of lindane as the causative agent are pointed out. A more rational policy for control of agents suspected of damaging bone marrow awaits improved understanding of pathogenetic mechanisms.
No takes yet. Share an insight, caveat, or question.
Morgan et al. (1980) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: